25 May 2013
Keywords: two-year, data, support, arava, activity, ra, new
Article | 15 November 1999
New two-year data from a study of Hoechst Marion Roussel's treatment forrheumatoid arthritis, Arava (leflunomide), show that the efficacy of ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.